Banner Health Children

1809 Articles Matching "billion"

Animal, Bug Bites a Billion-Dollar Burden

Dec 13, 2018 , WebMD
Attacks by mountain lions, bears and alligators get the most press, but the tiniest critters create the most work for emergency room doctors. Bug bites and stings account for more than half of all animal-related trips to the ER, the authors of a new study...
Read more

As ACOs Face Change, Group Touts $2.7B Medicare Savings

Dec 13, 2018 , Forbes
Accountable care organizations (ACOs) have saved Medicare nearly $2.7 billion from 2013 through 2016, an analysis released by the National Association of ACOs...
Read more

FDA gives Lupin’s generic Eliquis tentative approval

Dec 12, 2018 , Drug Store News - Retail
The FDA has given tentative clearance for Lupin's generic Eliquis, which had a market value of about $6.4 billion. Read More...
Read more

Animal attacks cost us more than $1 billion a year, and they're becoming more common

Dec 12, 2018 , CNN Health
Animal-related injuries lead to health care costs of more than $1 billion a year in the United States, according to a new study -- and they're happening more often....
Read more

When Skynet meets Elizabeth Arden: A beauty start-up sees A.I. as the key to flawless skin

Dec 11, 2018 , CNBC Health
The U.S. skincare market is worth an estimated $7 billion. Yet despite the wealth of products available promising flawless, ageless skin, consumers are frustrated by the low success rate. Start-up Proven Skincare believes it has the...
Read more
Demo

When Skynet meets Elizabeth Arden: A beauty startup sees A.I. as the key to flawless skin

Dec 09, 2018 , CNBC Health
The U.S. skincare market is worth an estimated $7 billion. Yet despite the wealth of products available promising flawless, ageless skin, consumers are frustrated by the low success rate. Skincare start-up Proven Beauty believes it has the...
Read more

Altria to invest $1.8 billion in cannabis company Cronos Group, exits some e-cig brands

Dec 08, 2018 , CNBC Health
Altria Group says it has agreed to buy a 45 percent stake in leading cannabinoid company Cronos Group for about $1.8 billion, a sign of the new world in which the tobacco company must...
Read more

Fentanyl Billionaire No More: John Kapoor's Net Worth Drops Below $1 Billion

Dec 08, 2018 , Forbes
The founder of embattled fentanyl manufacturer Insys Therapeutics is no longer a...
Read more

Judge Considers Delaying CVS-Aetna Merger, Citing Potential Anti-Competitive Harms

Dec 07, 2018 , Kaiser Health News
But antitrust experts say it's only possible for the Department of Justice to block the merger. DOJ approved the $70 billion deal in October. Meanwhile, CVS and Aetna are moving ahead with integration plans. Other industry news looks at CVS' new prescription drug-price plans and rising costs of Pitocin and...
Read more

Kroger’s Q3 reports sales decrease amid store revamps

Dec 07, 2018 , Drug Store News - Retail
Kroger’s total sales decreased 0.3% to $27.67 billion, same-store sales — excluding fuel — rose 1.6%, and digital sales grew over 60%. Read More...
Read more

Bayer halts vilaprisan drug trials due to toxicology data

Dec 06, 2018 , Reuters
Bayer said it halted trials testing its experimental uterine fibroids treatment vilaprisan, which it previously expected to generate peak annual sales of more than 1 billion euros ($1.1 billion), citing the risk of side effects....
Read more
Demo

Dollar General sees sales increase in Q3 results

Dec 05, 2018 , Drug Store News - Retail
The retailer's third-quarter sales increased 8.7% to $6.42 billion, above estimates of $6.39 billion, and saw same-store sales rise to a better-than-expected 2.7%. Read More...
Read more

P&G closes buy of Merck KGaA’s consumer health business

Dec 05, 2018 , Drug Store News - Retail
Procter & Gamble has completed its €3.2 billion acquisition of Darmstadt, Germany-based Merck KGaA’s consumer health business. Read More...
Read more

GSK Buys Tesaro For $5 Billion In Dramatic Bet On Cancer Genetics

Dec 04, 2018 , Forbes
The deal is a dramatic bet that the London-based drug giant can see opportunities connected to the genetics of cancer drugs better than the stock market. It fits into a framework outlined in July by Hal Barron, the widely respected pharma veteran who took over as GSK’s head of R&D last...
Read more

P&G closes buy of Merck KGaA’s consumer health businesses

Dec 04, 2018 , Drug Store News - Retail
Procter & Gamble has completed its €3.2 billion acquisition of Darmstadt, Germany-based Merck KGaA’s consumer health business. Read More...
Read more

Tesaro surges 60% after GlaxoSmithKline agrees to buy it for $5.1 billion

Dec 04, 2018 , CNBC Health
The deal represents a more than 60 percent premium to Tesaro's closing price on Friday of $46.38 per...
Read more

Federal judge warns CVS, Aetna to stay separate until he weighs in

Dec 04, 2018 , Modern Healthcare Breaking News
A federal judge told pharmacy giant CVS Health and the insurer Aetna that they have to keep their management separate until he weighs in on their $70 billion...
Read more

Healthcare Startups Raised $2.2 Billion In November

Dec 04, 2018 , Forbes
Venture capital fundraising among healthcare startups was down 25% to $2.18 billion in November compared the same month one year ago, according to an analysis conducted for Forbes by...
Read more

A Billionaire Vs. Drug Firms; Throwing Pharma Under The Bus; What A Vintage iPhone Means For Healthcare

Dec 01, 2018 , Forbes
Yesterday, some of the top minds in healthcare gathered near Columbus Circle in Manhattan for the seventh annual Forbes Healthcare Summit. Here are some...
Read more

Novartis CEO Vas Narasimhan On The Price Of Gene Therapies: 'It's A Challenge We Have To Solve'

Nov 30, 2018 , Forbes
In May Novartis announced that it had acquired the gene therapy pioneer AveXis in a $8.7 billion deal, but according to the the Swiss drug giant CEO Vas Narasimhan, he wishes he could have bought the company much...
Read more